Subscribe to RSS



Teva Pharmaceutical Announces CEO Retirement Plan and Named Successor – NASDAQ:TEVA

stocks-29

Teva Pharmaceutical Industries Ltd. recently declared about the retirement plan of its President and CEO, Shlomo Yanai, to be effective in May 2012. Moreover, the company also announced Dr. Jeremy Levin, who is a former senior executive at Bristol-Myers Squibb (NYSE:BMY) to replace Mr. Yanai at that time.

BMY declined 0.09% in final trading of 2011 to settle at $35.24 and completed year 2011 with a positive performance of 33.08%.[article_latestnews_1]

Yanai is getting retired from the company after TEVA’s shares lost the most since 2006 in last year amid rising competition for its No. 1 drug, a branded multiple sclerosis medicine called Copaxone.

Yanai had no track-record of pharmaceutical but spent $6.5 billion in 2011 to acquire U.S. biotech Cephalon Inc., then later in December said that Teva may not able to meet its long-term sales target of $31 billion by 2015.

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) kicked off the last session at an opening price of $40.36 and gained as much as to reach $40.97 but later by the trade end stock decreased 1.15% to $40.36.

On the other hand, its trade volume of 3.45 million shares was less than average trading capacity of 5.27 million shares. The week-performance of the company after last close appeared at -2.54% while completed year 2011 with a negative performance of -21.03% and a month-performance after last trade went up at 1.89%.

The stock price volatility was 1.53% for a week and 2.21% for a month as well as price volatility’s Average True Range for 14 days was 0.93 and its beta remained 0.29.
TEVA generated revenue of $17.05 billion in the following twelve months and earned $3.02 billion. The Company showed a positive 18.09% in the net profit margin and its operating margin which remained 19.19%. Company’s annual sales growth for the past five years was 25.15%.

The liquidity measure in recent quarter results of the company was recorded 1.13 as current ratio and on the other side the debt to equity ratio was 0.36 while long-term debt to equity ratio remained 0.19. TEVA had a cash of $1.19 per share and a book value per share as $25.83 in the most recent quarter.
[article_detail_ad_1]

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. galaxystocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer ( http://galaxystocks.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold galaxystocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

SCIF Hosts Targeted Medical Pharma, Inc. (TRGM), US Nuclear Corp, Pacific National Security & Meskita at Investor Gathering Tuesday, April 1, 2014 in Beverly Hills, CA

SCIF Hosts Targeted Medical Pharma, Inc. (TRGM), US Nuclear Corp, Pacific National Security & Meskita at Investor Gathering Tuesday, April 1, 2014 in Beverly Hills, CA

LOS ANGELES, March 28, 2014– WallStreet Research™, a leading independent analyst research and advisory firm focusing on the small and micro-cap marketplace, announced that it will hold the Southern California Investment Forum (SCIF) at Doma Beverly Hills Restaurant in Beverly Hills on Tuesday, April 1, 2014. The event will present selected emerging companies to an

Crown Equity Holdings Inc. (CRWE), Zaman & Co. and Mike Zaman Granted TRO Against Billy Barnwell, EQCO2, Inc, (CLNO) Arnold F. Sock and Shad Sullivan By Hon. Craig D. Karlan Judge

Crown Equity Holdings Inc. (CRWE), Zaman & Co. and Mike Zaman Granted TRO Against Billy Barnwell, EQCO2, Inc, (CLNO) Arnold F. Sock and Shad Sullivan By Hon. Craig D. Karlan Judge

  The honorable Superior Court Judge Craig D. Karlan granted a temporary restraining order against Billy Barnwell, EQCO2, Inc (CLNO), Arnold F. Sock, Discovery Carbon Environmental Securities and Shad Sullivan this time in the State of California. The Temporary Restraining Order could directly EQCO2, Inc. shareholders, (traded under the symbol CLNO) effectively shuts down all

EQCO2, Inc, Billy Barnwell, Arnold F. Sock and Shad Sullivan Being Sued By Crown Equity Holdings Inc, (CRWE) Zaman & Co. and Mike Zaman at the Superior Court of California, County of Los Angeles, Santa Monica Courthouse

EQCO2, Inc, Billy Barnwell, Arnold F. Sock and Shad Sullivan Being Sued By Crown Equity Holdings Inc, (CRWE) Zaman & Co. and Mike Zaman at the Superior Court of California, County of Los Angeles, Santa Monica Courthouse

Case alleges Breach of Contract, Breach of Implied Covenant of Good Faith & fair Dealing, Fraud, Constructive Fraud, Breach of Fiduciary Duty, Breach of Duty of Loyalty, Negligent Misrepresentation, Declaratory Relief, Conversion, Unjust Enrichment, Compelling Annual Shareholder Meeting and Violation of Business & Professions Code Section 17200. The lawsuit was filed on March 6, 2014

Crown Equity Holdings Inc’s CRWE-PR Network Surpasses the 100th Community Website – Now Covers Nevada

Crown Equity Holdings Inc’s CRWE-PR Network Surpasses the 100th Community Website – Now Covers Nevada

Las Vegas, North Las Vegas, Henderson, Carson City and Reno among cities being covered in Nevada. CRWE-PR is continuing to increase its foot print community targeted publications of websites with local news, information and business directory delivery. In an effort to distinguish itself and to strengthen its brand for readers and business owners, the networks

SCIF Hosts Hinto Energy (HENI), Targeted Medical Pharma (TRGM) & Pacific National Security at Investor Gathering

SCIF Hosts Hinto Energy (HENI), Targeted Medical Pharma (TRGM) & Pacific National Security at Investor Gathering

  South Florida Investment Forum Hosts Investor Gatherings on Tuesday, March 4th in Boca Raton, FL; Wednesday, March 5th in Miami, FL; and Thursday, March 6th in West Palm Beach, FL   MIAMI, FL March 3, 2013– WallStreet Research™, a leading independent analyst research and advisory firm focusing on the small and micro-cap marketplace, announced that it will

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.